BB Biotech (Switzerland) Insiders
| BION Stock | CHF 32.45 0.05 0.15% |
Recap of BB Biotech's management performance can provide insight into the venture performance.
BION |
| Symbol | BION |
| Name | BB Biotech AG |
| Type | Stock |
| Country | Switzerland |
| Exchange | SW |
Information on BB Biotech AG Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Thematic Opportunities
Explore Investment Opportunities
BB Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.0411) % which means that it has lost $0.0411 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.265) %, meaning that it generated substantial loss on money invested by shareholders. BB Biotech's management efficiency ratios could be used to measure how well BB Biotech manages its routine affairs as well as how well it operates its assets and liabilities.BB Biotech Workforce Comparison
BB Biotech AG is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 606. BB Biotech claims roughly 10.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
BB Biotech AG Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. BB Biotech AG Price Series Summation is a cross summation of BB Biotech price series and its benchmark/peer.
About BB Biotech Management Performance
The success or failure of an entity such as BB Biotech AG often depends on how effective the management is. BB Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BION management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BION management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland. BB BIOTECH operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange.
Please note, the imprecision that can be found in BB Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BB Biotech AG. Check BB Biotech's Beneish M Score to see the likelihood of BB Biotech's management manipulating its earnings.
Additional Tools for BION Stock Analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.